Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical modelling study

Herzog, Sereina A; Althaus, Christian L; Heijne, Janneke Cm; Oakeshott, Pippa; Kerry, Sally; Hay, Phillip; Low, Nicola (2012). Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical modelling study. BMC infectious diseases, 12, p. 187. London: BioMed Central 10.1186/1471-2334-12-187

[img]
Preview
Text
1471-2334-12-187.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (524kB) | Preview
[img]
Preview
Text
Herzog BMCInfectDis 2012_Appendix.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (256kB) | Preview
[img]
Preview
Text
Herzog BMCInfectDis 2012.pdf - Accepted Version
Available under License Creative Commons: Attribution (CC-BY).

Download (398kB) | Preview

Background Pelvic inflammatory disease (PID) results from the ascending spread of microorganisms from the vagina and endocervix to the upper genital tract. PID can lead to infertility, ectopic pregnancy and chronic pelvic pain. The timing of development of PID after the sexually transmitted bacterial infection Chlamydia trachomatis (chlamydia) might affect the impact of screening interventions, but is currently unknown. This study investigates three hypothetical processes for the timing of progression: at the start, at the end, or throughout the duration of chlamydia infection. Methods We develop a compartmental model that describes the trial structure of a published randomised controlled trial (RCT) and allows each of the three processes to be examined using the same model structure. The RCT estimated the effect of a single chlamydia screening test on the cumulative incidence of PID up to one year later. The fraction of chlamydia infected women who progress to PID is obtained for each hypothetical process by the maximum likelihood method using the results of the RCT. Results The predicted cumulative incidence of PID cases from all causes after one year depends on the fraction of chlamydia infected women that progresses to PID and on the type of progression. Progression at a constant rate from a chlamydia infection to PID or at the end of the infection was compatible with the findings of the RCT. The corresponding estimated fraction of chlamydia infected women that develops PID is 10% (95% confidence interval 7-13%) in both processes. Conclusions The findings of this study suggest that clinical PID can occur throughout the course of a chlamydia infection, which will leave a window of opportunity for screening to prevent PID.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine

UniBE Contributor:

Herzog, Sereina; Althaus, Christian; Min, Johanna and Low, Nicola

ISSN:

1471-2334

Publisher:

BioMed Central

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:35

Last Modified:

10 Sep 2017 10:36

Publisher DOI:

10.1186/1471-2334-12-187

PubMed ID:

22883325

Web of Science ID:

000311719900001

BORIS DOI:

10.7892/boris.13975

URI:

https://boris.unibe.ch/id/eprint/13975 (FactScience: 220696)

Actions (login required)

Edit item Edit item
Provide Feedback